Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Scot Harper, Ph.D., President of SLH Group, a life sciences consulting company and previously CEO of Novartis Clinical Operations, address some steps life science industry clinical development executives can take to improve the productivity and performance of their clinical trials in the future.
To get a flavor for how complex clinical trials are to execute and, therefore, why they are so expensive, all one needs to do is review the task list/budget prepared by any CRO for a full-service clinical trial.